Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1976 Oct 1;144(4):882–896. doi: 10.1084/jem.144.4.882

Control of B-lymphocyte function. I. Inactivation of mitogenesis by interactions with surface immunoglobulin and Fc-receptor molecules

PMCID: PMC2190431  PMID: 1086339

Abstract

Mouse spleen cells were incubated with anti-Ig antibodies for 1 h, washed, exposed to LPS for 1 h, washed, and their DNA synthetic responses assayed 2 days later. It was shown that the 1-h incubation with anti-Ig antibodies produced a profound, internal, and long lasting state of inactivation in the B cells. Experiments with anti-Ig fragments and other ligands showed that the inactivation occurred optimally when both surface Ig molecules and Fc receptors were bound simultaneously. The role of the classical capping and clearing cycle was also investigated. It was shown that capping and clearing were neither necessary nor sufficient for the inactivation to occur, and that the signals, but only secondarily the ligands themselves, were transmitted across the membrane. Capping and clearing were viewed as a natural regulatory mechanism by which the B cell attempts to clear its membrane of perturbations and signals from the exterior.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbas A. K., Unanue E. R. Interrelationships of surface immunoglobulin and Fc receptors on mouse B lymphocytes. J Immunol. 1975 Dec;115(6):1665–1671. [PubMed] [Google Scholar]
  2. Andersson J., Bullock W. W., Melchers F. Inhibition of mitogenic stimulation of mouse lymphocytes by anti-mouse immunoglobulin antibodies. I. Mode of action. Eur J Immunol. 1974 Nov;4(11):715–722. doi: 10.1002/eji.1830041103. [DOI] [PubMed] [Google Scholar]
  3. Andersson J., Edelman G. M., Möller G., Sjöberg O. Activation of B lymphocytes by locally concentrated concanavalin A. Eur J Immunol. 1972 Jun;2(3):233–235. doi: 10.1002/eji.1830020307. [DOI] [PubMed] [Google Scholar]
  4. Ault K. A., Unanue E. R. Events after the binding of antigen to lymphocytes: removal and regeneration of the antigen receptor. J Exp Med. 1974 May 1;139(5):1110–1124. doi: 10.1084/jem.139.5.1110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ault K. A., Unanue E. R., Katz D. H., Benacerraf B. Failure of lymphocytes to reexpress antigen receptors after brief interaction with a tolerogenic D-amino acid copolymer. Proc Natl Acad Sci U S A. 1974 Aug;71(8):3111–3114. doi: 10.1073/pnas.71.8.3111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bona C., Damais C., Chedid L. Blastic transformtion of mouse spleen lymphocytes by a water-soluble mitogen extracted from Nocardia. Proc Natl Acad Sci U S A. 1974 May;71(5):1602–1606. doi: 10.1073/pnas.71.5.1602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Coutinho A., Möller G. Thymus-independent B-cell induction and paralysis. Adv Immunol. 1975;21:113–236. doi: 10.1016/s0065-2776(08)60220-5. [DOI] [PubMed] [Google Scholar]
  8. Cuatrecasas P. Membrane receptors. Annu Rev Biochem. 1974;43(0):169–214. doi: 10.1146/annurev.bi.43.070174.001125. [DOI] [PubMed] [Google Scholar]
  9. Elson C. J., Singh J., Taylor R. B. The effect of capping by anti-immunoglobulin antibody on the expression of cell surface immunoglobulin and on lymphocyte activation. Scand J Immunol. 1973;2(2):143–149. doi: 10.1111/j.1365-3083.1973.tb02025.x. [DOI] [PubMed] [Google Scholar]
  10. Feldmann M., Greaves M. F., Parker D. C., Rittenberg M. B. Direct triggering of B lymphocytes by insolubilized antigen. Eur J Immunol. 1974 Sep;4(9):591–597. doi: 10.1002/eji.1830040903. [DOI] [PubMed] [Google Scholar]
  11. Gordon J., Murgita R. A. Suppression and augmentation of the primary in vitro immune response by different classes of antibodies. Cell Immunol. 1975 Feb;15(2):392–402. doi: 10.1016/0008-8749(75)90017-9. [DOI] [PubMed] [Google Scholar]
  12. Greaves M. F., Bauminger S. Activation of T and B lymphocytes by insoluble phytomitogens. Nat New Biol. 1972 Jan 19;235(55):67–70. doi: 10.1038/newbio235067a0. [DOI] [PubMed] [Google Scholar]
  13. Havas H. F. The effect of the carrier protein on the immune response and on the induction of tolerance in mice to the 2,4-dinitrophenyl determinant. Immunology. 1969 Dec;17(6):819–829. [PMC free article] [PubMed] [Google Scholar]
  14. Katz D. H., Davie J. M., Paul W. E., Benacerraf B. Carrier function in anti-hapten antibody responses. IV. Experimental conditions for the induction of hapten-specific tolerance or for the stimulation of anti-hapten anamnestic responses by "nonimmunogenic" hapten-polypeptide conjugates. J Exp Med. 1971 Jul 1;134(1):201–223. doi: 10.1084/jem.134.1.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Katz D. H., Unanue E. R. Critical role of determinant presentation in the induction of specific responses in immunocompetent lymphocytes. J Exp Med. 1973 Apr 1;137(4):967–990. doi: 10.1084/jem.137.4.967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kishimoto T., Ishizaka K. Regulation of antibody response in vitro. IX. Induction of secondary anti-hapten IgG antibody response by anti-immunoglobulin and enhancing soluble factor. J Immunol. 1975 Feb;114(2 Pt 1):585–591. [PubMed] [Google Scholar]
  17. Kishimoto T., Miyake T., Nishizawa Y., Watanabe T., Yamamura Y. Triggering mechanism of B lymphocytes. I. Effect of anti-immunoglobulin and enhancing soluble factor on differentiation and proliferation of B cells. J Immunol. 1975 Nov;115(5):1179–1184. [PubMed] [Google Scholar]
  18. Lonai P., McDevitt H. O. Genetic control of the immune response: in vitro stimulation of lymphocytes by (T,G)-A--L, (H,G)-A--L, and (Phe,G)-A--L. J Exp Med. 1974 Oct 1;140(4):977–994. doi: 10.1084/jem.140.4.977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Melchers F., Braun V., Galanos C. The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen. J Exp Med. 1975 Aug 1;142(2):473–482. doi: 10.1084/jem.142.2.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nicholas R., Sinclair S. C. Regulation of the immune response. I. Reduction in ability of specific antibody to inhibit long-lasting IgG immunological priming after removal of the Fc fragment. J Exp Med. 1969 Jun 1;129(6):1183–1201. doi: 10.1084/jem.129.6.1183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nossal G. J., Layton J. E. Antigen-induced aggregation and modulation of receptors on hapten-specific B lymphocytes. J Exp Med. 1976 Mar 1;143(3):511–528. doi: 10.1084/jem.143.3.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Parker D. C. Stimulation of mouse lymphocytes by insoluble anti-mouse immunoglobulin. Nature. 1975 Nov 27;258(5533):361–363. doi: 10.1038/258361a0. [DOI] [PubMed] [Google Scholar]
  23. Perkins W. D., Karnovsky M. J., Unanue E. R. An ultrastructural study of lymphocytes with surface-bound immunoglobulin. J Exp Med. 1972 Feb 1;135(2):267–276. doi: 10.1084/jem.135.2.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ryan J. L., Arbeit R. D., Dickler H. B., Henkart P. A. Inhibition of lymphocyte mitogenesis by immobilized antigen-antibody complexes. J Exp Med. 1975 Oct 1;142(4):814–826. doi: 10.1084/jem.142.4.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. SELL S., GELL P. G. STUDIES ON RABBIT LYMPHOCYTES IN VITRO. I. STIMULATION OF BLAST TRANSFORMATION WITH AN ANTIALLOTYPE SERUM. J Exp Med. 1965 Aug 1;122:423–440. doi: 10.1084/jem.122.2.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Schrader J. W. Antagonism of B lymphocyte mitogenesis by anti-immunoglobulin antibody. J Immunol. 1975 Aug;115(2):323–326. [PubMed] [Google Scholar]
  27. Schuffler C., Dray S. In vitro suppression ofimmunoglobulin allotype synthesis by Fab and F(ab')2 fragments of anti-allotype antibody. Cell Immunol. 1974 Mar 30;11(1-3):367–376. doi: 10.1016/0008-8749(74)90035-5. [DOI] [PubMed] [Google Scholar]
  28. Sidman C. L., Unanue E. R. Development of B lymphocytes. I. Cell populations and a critical event during ontogeny. J Immunol. 1975 Jun;114(6):1730–1735. [PubMed] [Google Scholar]
  29. Sidman C. L., Unanue E. R. Receptor-mediated inactivation of early B lymphocytes. Nature. 1975 Sep 11;257(5522):149–151. doi: 10.1038/257149a0. [DOI] [PubMed] [Google Scholar]
  30. Trump G. N. In vitro response of mouse spleen cells to the solid phase immunogen DNP-O-Bio-Gel. J Immunol. 1975 Feb;114(2 Pt 1):682–687. [PubMed] [Google Scholar]
  31. Unanue E. R., Karnovsky M. J., Engers H. D. Ligand-induced movement of lymphocyte membrane macromolecules. 3. Relationship between the formation and fate of anti-Ig-surface Ig complexes and cell metabolism. J Exp Med. 1973 Mar 1;137(3):675–689. doi: 10.1084/jem.137.3.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Unanue E. R., Perkins W. D., Karnovsky M. J. Ligand-induced movement of lymphocyte membrane macromolecules. I. Analysis by immunofluorescence and ultrastructural radioautography. J Exp Med. 1972 Oct 1;136(4):885–906. doi: 10.1084/jem.136.4.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Watanabe T., Kishimoto T., Miyake T., Nishizawa Y., Inoue H. Triggering mechanism of B lymphocytes. II. Induction of ornithine decarboxylase in B cells by anti-immunoglobulin and enhancing soluble factor. J Immunol. 1975 Nov;115(5):1185–1190. [PubMed] [Google Scholar]
  34. Watson J., Riblet R. Genetic control of responses to bacterial lipopolysaccharides in mice. II. A gene that influences a membrane component involved in the activation of bone marrow-derived lymphocytes by lipipolysaccharides. J Immunol. 1975 May;114(5):1462–1468. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES